Page last updated: 2024-09-04

cinacalcet and Hepatocellular Carcinoma

cinacalcet has been researched along with Hepatocellular Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Du, J; Ge, F; He, Q; Qian, M; Weng, Q; Yang, B; Zheng, L; Zhu, H1

Other Studies

1 other study(ies) available for cinacalcet and Hepatocellular Carcinoma

ArticleYear
The calcimimetic agent cinacalcet inhibits hepatocellular carcinoma via YAP/TAZ suppression.
    Die Pharmazie, 2021, 10-01, Volume: 76, Issue:10

    Topics: Adaptor Proteins, Signal Transducing; Carcinoma, Hepatocellular; Cinacalcet; Humans; Liver Neoplasms; Signal Transduction; Trans-Activators; Transcription Factors; Transcriptional Coactivator with PDZ-Binding Motif Proteins; YAP-Signaling Proteins

2021